Skip to main content

Table 3 Multiple linear regression models to predict difference in adherence between visits (V2-V1) for total ©MMAS-8 score, intentional non-adherence ©MMAS-8 score and unintentional non-adherence ©MMAS-8 score (N = 138)

From: Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial

  Total Intentional Unintentional
B 95% CI for B p value B 95% CI for B p value B 95% CI for B p value
Constant −1.059 −3.05 – 0.93 0.294 −0.335 −1.84 – 1.17 0.661 −0.724 −1.84 - 0.39 0.201
MUR effect for low adherent patients 1.201 0.16–2.25 0.025 0.841 0.05–1.63 0.038 0.360 −0.23 - 0.95 0.226
Baseline adherencea −0.973 −1.68 - -0.26 0.008 −0.540 −1.08 - -0.00 0.049 −0.433 −0.83 - -0.04 0.033
Interaction [MUR effect* baseline adherence] −1.229 −2.37 - -0.09 0.035 −0.812 −1.68 – 0.05 0.066 −0.416 −1.06 - 0.22 0.200
Self-reported current health statusb [1,2,3,4,5] 0.342 0.03–0.65 0.032 0.290 0.05–0.53 0.016 0.052 −0.12 - 0.23 0.558
Gender (male vs. female) 0.063 −0.39 – 0.52 0.785 −0.065 −0.41 – 0.28 0.712 0.128 −0.13 - 0.38 0.325
Ageb [years] 0.026 −0.002 – 0.05 0.068 0.006 −0.02 – 0.03 0.587 0.020 0.00–0.04 0.012
Educationb [1,2,3,4] −0.194 − 0.44 – 0.05 0.114 0.007 −0.18 – 0.19 0.936 −0.201 − 0.34 - -0.07 0.004
Employment status (retired vs. non-retired) −0.403 −1.18 – 0.37 0.305 −0.198 −0.78 – 0.39 0.506 −0.206 − 0.64 - 0.23 0.349
Number of Rx medicines for regular useb −0.005 −0.10 – 0.09 0.918 0.007 −0.07 – 0.08 0.844 −0.012 −0.07 - 0.04 0.653
Different pharmaceutical formsc 0.243 −0.20 – 0.69 0.280 0.065 −0.27 – 0.40 0.704 0.179 −0.07 - 0.43 0.157
(Co)paying for medicines (no vs. yes) −0.266 −0.68 – 0.15 0.202 −0.391 − 0.70 - -0.08 0.014 0.125 −0.11 - 0.36 0.284
Model summary N = 138; R2 = 0,238; p < 0,001 N = 138; R2 = 0,176; p = 0,009 N = 138; R2 = 0,216; p < 0,001
  1. a baseline moderate and high versus baseline low adherence in control group
  2. b included as scale variable
  3. c different pharmaceutical forms vs. only tablets and capsules